→ Dividend Expert Reveals His Biggest Earning Secret…Free (From Oxford Club)
Cross Country Healthcare, Inc. (NASDAQ:CCRN – Get Rating) – Oppenheimer said in a research note issued to investors on Thursday, January 19, that Cross Country Healthcare’s first quarter 2024 earnings per share ( EPS) estimates have been released. Oppenheimer analyst M. Wiederhorn expects the business services provider to post his earnings per share of $0.79 in the quarter. Cross Country Healthcare’s current consensus annual earnings estimate is $5.07 per share. Oppenheimer also forecasts Cross Country Healthcare’s second-quarter 2024 earnings at EPS of $0.84, third-quarter 2024 earnings at EPS of $0.89, fourth-quarter 2024 earnings at EPS of $0.91, and 2025 earnings at EPS. Estimated at $3.59.
Other research analysts have also recently published research reports on the company. Truist Financial downgraded Cross Country Healthcare from ‘buy’ to ‘hold’ with a price target of $36.00. In a report on Wednesday, October 5th. They noted that the move was an evaluation call. Barrington Research has increased Cross Country Healthcare’s target price from $41.00 to $45.00, giving it an “excellent” rating in its research report on Monday, November 7th. StockNews.com began covering Cross Country Healthcare stock in its research report on Wednesday, October 12th. They issued a “Hold” rating on the stock. Finally, Credit Suisse Group raised its price target on cross-country healthcare stocks to $31.00 in its research notes on Thursday, November 24th. Three of his analysts assigned the stock a hold rating and three of his analysts assigned a buy rating to the stock. According to MarketBeat data, Cross Country Healthcare has an average rating of “moderate buy” with a consensus price target of $36.20.
Cross-Country Healthcare stock gains 0.9%
CCRN opened at $26.40 on Friday. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt to equity ratio of 0.31. Cross Country Healthcare has a 12-month low of $15.26 and a 12-month high of $40.12. The company has a 50-day moving average of $30.39 and a 200-day moving average of $29.03. The company has a market capitalization of $984.59 million, a PE ratio of 4.38, a P/E ratio of 1.47 and a beta of 1.06.
Cross Country Healthcare (NASDAQ:CCRN – Get Rating) last reported quarterly earnings data on Wednesday, November 2nd. The business services provider posted earnings per share of $1.07 for the quarter, beating consensus expectations of $0.96 by $0.11. The company’s revenue for the quarter he had $636.1 million, while analyst estimates put him at $617.93 million. Cross Country Healthcare’s return on equity was 56.53% and net profit margin was 8.06%.
insider trading
In another Cross Country Healthcare news, VP Cynthia Ann Grieco sold 1,071 shares in the company in a transaction on Monday, November 28th. The shares sold for an average of $36.00 and the total trading value was her $38,556.00. Following the closing of the sale, the Vice President now owns 11,950 direct shares of the company’s stock valued at approximately $430,200. The deal is disclosed in documents filed with the SEC and can be accessed at the SEC’s website. Her 5.00% of the shares are now owned by company insiders.
institution inflow and outflow
Several hedge funds have recently changed their CCRN holdings. Advisor Group Holdings Inc. increased its position in Cross Country Healthcare by 176.0% in the first quarter. Advisor Group Holdings Inc. now owns 8,179 shares of the business service provider worth $177,000 after purchasing an additional 5,216 shares in him last quarter. JPMorgan Chase & Co. increased its position in cross-country healthcare by 118.6% in the first quarter. JPMorgan Chase & Co. now owns 256,032 shares in the business services provider worth $5,548,000 after purchasing an additional 138,906 shares in him last quarter. US Bancorp DE purchased a new position in Cross Country Healthcare stock for approximately $27,000 in the first quarter. Citigroup Inc. increased its Cross Country Healthcare stock position by 5.9% in the first quarter. Citigroup Inc. now owns 31,568 shares in the business services provider worth $684,000 after purchasing an additional 1,751 shares in him last quarter. Finally, PNC Financial Services Group Inc. increased its cross-country healthcare stake by 9.4% in the first quarter. PNC Financial Services Group Inc. now owns 23,527 shares of the business service provider worth $510,000 after acquiring an additional 2,027 shares during this period. Hedge funds and other institutional investors own 95.99% of the company’s shares.
About Cross Country Healthcare
(get rating)
Cross Country Healthcare, Inc provides talent management and other consulting services to US healthcare clients. The company operates in his two segments: Nurse and Associated Staffing and Physician Staffing. The Nurses and Related Staffing segment provides traditional staffing, including temporary and permanent placements of traveling nurses and related professionals, local nurses and related staffing. Staffing solutions for Registered Nurses, Licensed Practical Nurses, Certified Nursing Assistants, Practitioners, Pharmacists, and other relevant professionals on daily and short-term assignments. Clinical and non-clinical experts in long-term contract assignments as well as workforce solutions such as MSP, RPO and consulting services.
Related item
This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.
Listen to this before you consider cross country healthcare.
MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Cross Country Healthcare isn’t on the list. bottom.
Cross Country Healthcare currently holds a ‘moderate buy’ rating among analysts, although top-rated analysts believe these five stocks are better buys.
See 5 stocks here
